Further, CAV1 can protect lung cancer cells from anoikis by preventing ubiquitin-mediated degradation of myeloid cell leukemia sequence 1 (MCL1), a member of the anti-apoptotic BCL-2 family [196]. This evidence concerns the gene BCL2 and lung cancer.